Tuberc Respir Dis.
2013 Dec;75(6):231-235.
Druggable Targets of Squamous Cell Lung Cancer
- Affiliations
-
- 1Division of Pulmonology, Department of Internal Medicine, Korea Cancer Center Hospital, Seoul, Korea. cheol@kcch.re.kr
Abstract
- Knowledge of molecular pathogenesis of non-small cell lung cancer has increased remarkably and changed the principles of treatment, especially during the past decade. These advancements have been limited mainly to adenocarcinoma of the lung. Recently, genetic alterations in squamous cell lung cancer (SQCLC) have been detailed and positive results of clinical trials using agents targeting these changes have indicated the potential for improved treatment outcomes for SQCLC.
Keyword
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- The change of squamous cell cancer antigen(SCC Ag) level as a tumor marker in squamous cell lung cancer
- Metastasis-associated protein 1: a druggable target in cancer treatment
- Multiple primary lung cancer: Synchronous small cell lung carcinoma and squamous cell carcinoma
- Basaloid Squamous Cell Carcinoma of the Lung: Two Case Reports with CT Imaging Findings
- Synchronous Primary Lung Cancer with Differrent Squamous cell Carcinoma: One Case Report
